Patents by Inventor Paul J. Galley
Paul J. Galley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220287563Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: ApplicationFiled: June 2, 2022Publication date: September 15, 2022Applicant: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Publication number: 20220257118Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.Type: ApplicationFiled: May 6, 2022Publication date: August 18, 2022Applicant: Roche Diabetes Care, Inc.Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
-
Patent number: 11382507Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: GrantFiled: September 23, 2019Date of Patent: July 12, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Patent number: 11350822Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.Type: GrantFiled: August 13, 2019Date of Patent: June 7, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Erica Diebold
-
Patent number: 11284815Abstract: A diabetes management system includes a handheld medical device, a mobile computing device, and a diabetes management application. The handheld medical device is configured to measure glucose in a sample of fluid residing in a test strip and associate a measurement time with the glucose measurement. The diabetes management application is configured to request a current device time from the RTC, determine a first device delta time by determining a difference between the current device time and an internal clock time, and associate a first timestamp with a glucose measurement, wherein the first timestamp is equal to the measurement time plus the first device delta time.Type: GrantFiled: April 2, 2014Date of Patent: March 29, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Eric S. Carlsgaard, Paul J. Galley, Mark G. Mears, Benoit P. Menez, Hemlata Nayee, Jose Salazar-Galindo
-
Publication number: 20200015680Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: ApplicationFiled: September 23, 2019Publication date: January 16, 2020Applicant: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Patent number: 10522247Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.Type: GrantFiled: September 20, 2016Date of Patent: December 31, 2019Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
-
Publication number: 20190371467Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.Type: ApplicationFiled: August 13, 2019Publication date: December 5, 2019Applicant: Roche Diabetes Care, Inc.Inventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Eric Diebold
-
Patent number: 10458973Abstract: According to some embodiments of the present disclosure, a device and method for determining an allowable amount of blood glucose (bG) of a patient is disclosed. The method further includes receiving a current bG measurement, determining a target bG value, and determining a correction delta bG value based on one or more advice history records. The method includes determining a correction meal rise value and determining a maximum allowed bG value based on the target bG value, the correction delta bG value, and the correction meal rise value. The method includes setting the allowable amount of bG value equal to the maximum allowed bG value when the current bG measurement is greater than the target bG value and determining the allowable amount of bG value using the target bG value and the correction delta bG value when the current bG measurement is less than the target bG value.Type: GrantFiled: August 24, 2012Date of Patent: October 29, 2019Assignee: Roche Diabetes Care, Inc.Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
-
Patent number: 10456036Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: GrantFiled: June 18, 2010Date of Patent: October 29, 2019Assignee: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Patent number: 10437962Abstract: Embodiments related to a system and method managing the implementation, execution, data collection, data analysis and status reporting of a structured collection procedure running on a portable, hand-held collection device are disclosed. The collection device performing the structured collection procedure has program instructions that when executed by a processor cause the processor to initiate automatically a schedule of events of the structured collection procedure upon one or more entry criteria being met at some unknown time, store in memory patient data collected in accordance to the schedule of events, end automatically the structured collection procedure upon one or more exit criteria being met at some unknown time. Status reporting can be provided throughout the execution of the collection procedure.Type: GrantFiled: June 18, 2010Date of Patent: October 8, 2019Assignee: ROCHE DIABETES CARE INCInventors: Abhishek S. Soni, Paul J. Galley, Alan Greenburg, Steven Bousamra, Stefan Weinert, Eric Diebold
-
Patent number: 10251583Abstract: A device and method for delivering insulin to a patient is disclosed. The method includes receiving an amount of insulin to deliver to a patient and beginning delivery of the insulin to the patient. The method further includes monitoring the delivery of the insulin to determine whether the insulin pump is able to deliver the entire amount of insulin and maintaining a timer until the insulin pump recommences the delivery of the insulin. The method includes comparing an amount of time indicated by the timer to a threshold. The method further includes generating a first insulin delivery record indicating that a first amount of insulin was delivered when the amount of time indicated by the timer is less than the threshold and a second insulin record indicating that a second amount of insulin was delivered when the amount of time indicated by the timer is greater than the threshold.Type: GrantFiled: August 24, 2012Date of Patent: April 9, 2019Assignee: ROCHE DIABETES CARE, INC.Inventors: Nicole Bernini, Paul J. Galley, Stefan Lindegger, John F. Price, Reto Sigrist, Robin S. Wagner, Richard W. Wilson
-
Patent number: 9965587Abstract: A method includes: measuring a blood glucose (bG) level in a blood sample; storing the bG level and a time of receipt of the blood sample; storing a classification of the blood sample; in response to the receipt of the blood sample, selecting a group of stored bG levels having the classification of the blood sample and that were received within a predetermined period before receipt of the blood sample; calculating a bG evaluation parameter from the selected bG levels; evaluating the bG evaluation parameter in relation to first predetermined criteria, the first predetermined criteria including a first threshold indicative of a high bG level or a low bG level; selectively displaying an indication of recognition of a pattern in the selected bG levels when the bG evaluation parameter is greater than or less than the first threshold; and selectively removing the indication from the display.Type: GrantFiled: July 8, 2013Date of Patent: May 8, 2018Assignee: Roche Diabetes Care, Inc.Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Horst Merkle, Christen A. Rees, Michelle M. Stevens, Scott A. Wooldridge
-
Patent number: 9786024Abstract: According to some aspects of the present disclosure a method for presenting a GUI for modifying medical data on a handheld medical device is disclosed. The method includes determining a correction bolus amount and a meal bolus amount for the patient. The method also includes presenting the GUI on a display of the medical device and presenting the correction bolus amount, the meal bolus amount and a total bolus amount in the GUI. The method also includes presenting a correction bolus amount modification field and a meal bolus amount field in the GUI. The correction bolus amount modification field and the meal bolus amount modification field allow the patient to provide input to modify the correction bolus amount and meal bolus amount, respectively. The method further includes receiving the input and generating an advice history record based on the input.Type: GrantFiled: August 24, 2012Date of Patent: October 10, 2017Assignee: Roche Diabetes Care, Inc.Inventors: Paul J. Galley, Alan M. Greenburg, Marshall M. Parker, John F. Price, Robin S. Wagner, Richard W. Wilson
-
Publication number: 20170011176Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.Type: ApplicationFiled: September 20, 2016Publication date: January 12, 2017Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
-
Patent number: 9419704Abstract: A handheld diabetes manager is presented with an improved graphical user interface for a bolus calculator. The bolus calculator is configured to receive blood glucose measurements from a blood glucose measurement module and operates, in response to an input, to compute an insulin recommendation for a patient based in part on the blood glucose measurements. The graphical user interface for the bolus calculator includes a health adjustment screen that enables a user to input a value for health events associated with the insulin recommendation, where the input value represents a cumulative effect of the health events on insulin of the patient and the health adjustment screen presents a different icon for each of the health events associated with the insulin recommendation.Type: GrantFiled: September 3, 2015Date of Patent: August 16, 2016Assignee: Roche Diabetes Care, Inc.Inventors: Paul J. Galley, Mark Mears, Phillip Edgar Pash, Vincent R. Rizzo, Bettina Steiner, Kristin M. Westerfield, Richard W. Wilson
-
Publication number: 20150377895Abstract: A handheld diabetes manager is presented with an improved graphical user interface for a bolus calculator. The bolus calculator is configured to receive blood glucose measurements from a blood glucose measurement module and operates, in response to an input, to compute an insulin recommendation for a patient based in part on the blood glucose measurements. The graphical user interface for the bolus calculator includes a health adjustment screen that enables a user to input a value for health events associated with the insulin recommendation, where the input value represents a cumulative effect of the health events on insulin of the patient and the health adjustment screen presents a different icon for each of the health events associated with the insulin recommendation.Type: ApplicationFiled: September 3, 2015Publication date: December 31, 2015Inventors: Paul J. GALLEY, Mark G. MEARS, Phillip E. PASH, Vincent R. RIZZO, Bettina STEINER, Kristen M. WESTERFIELD, Richard W. WILSON
-
Patent number: 9213802Abstract: A method of improving updatability of entry, adherence, and exit criteria stored in memory of a handheld diabetes management device, the method includes: providing the handheld diabetes management device with a blood glucose (bG) measurement engine that measures a bG level in a sample of blood of a user and that generates sample data indicative of the bG level; providing the handheld diabetes management device with the memory and a touchscreen display; providing the handheld diabetes management device with a processor module that is in communication with the bG measurement engine, the touchscreen display, and the memory; storing firmware that is executable by the processor module for performing operations to carry out a structured bG test in a non-modifiable portion of the memory; and storing the entry, adherence, and exit criteria in a modifiable portion of the memory.Type: GrantFiled: October 15, 2010Date of Patent: December 15, 2015Assignee: Roche Diabetes Care, Inc.Inventors: John F. Price, Paul J. Galley
-
Publication number: 20150324520Abstract: The handheld blood glucose meter creates blood glucose records having contextual information to improve filtering of blood glucose records for improved healthcare decisions. The contextual information includes events and associated sub-events. The user selects an event indicator from the plurality of event indicators, and the meter associates the blood glucose measurement with an event that corresponds to the event indicator. The user selects a sub-event indicator from the plurality of sub-event indicators, and the meter associates the blood glucose measurement with a sub-event that corresponds to the sub-event indicator. The user repeats the preceding steps to obtain a plurality of blood glucose measurements with associated events and sub-events. The user selects data filtering, a predetermined range of blood glucose measurements along with an event and sub-event to produce a filter result meeting these criteria.Type: ApplicationFiled: May 12, 2014Publication date: November 12, 2015Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Timothy N. Aykroyd, Amy C. Day, Paul J. Galley, Erin K. McKinney, Mark G. Mears, Michelle M. Stevens, Nicole D. Tillery
-
Patent number: 9136939Abstract: A handheld diabetes manager is presented with an improved graphical user interface for a bolus calculator. The bolus calculator is configured to receive blood glucose measurements from a blood glucose measurement module and operates, in response to an input, to compute an insulin recommendation for a patient based in part on the blood glucose measurements. The graphical user interface for the bolus calculator includes a health adjustment screen that enables a user to input a value for health events associated with the insulin recommendation, where the input value represents a cumulative effect of the health events on insulin of the patient and the health adjustment screen presents a different icon for each of the health events associated with the insulin recommendation.Type: GrantFiled: August 27, 2012Date of Patent: September 15, 2015Assignee: Roche Diabetes Care, Inc.Inventors: Paul J. Galley, Mark G. Mears, Phillip E. Pash, Vincent R. Rizzo, Bettina Steiner, Kristin M. Westerfield, Richard W. Wilson